Literature DB >> 31638245

SRPX and HMCN1 regulate cancer‑associated fibroblasts to promote the invasiveness of ovarian carcinoma.

Chao Lien Liu1, Hung Wei Pan2, Pao Ling Torng3, Ming Huei Fan1, Tsui Lien Mao4.   

Abstract

Cancer‑associated fibroblasts (CAFs) are known to be essential in cancer initiation and development. However, the role of CAFs in promoting ovarian cancer (OC) invasion remains to be fully elucidated. To address this in the present study, 49 clinical OC specimens were used to evaluate the roles of CAFs in promoting ovarian tumor migration and invasion and disease progression. It was found that the sushi repeat‑containing protein, X‑linked (SRPX) and hemicentin 1 (HMCN1) genes were significantly upregulated in CAFs from high‑grade serous carcinoma (HGSC) and clear cell carcinoma (CCC) samples, the two major histological types of OC with frequently poor patient survival rates. The short hairpin (sh)RNA‑mediated silencing of SRPX and HMCN1 in fibroblasts significantly suppressed the Transwell invasive activities of OC cells. Further experiments showed that SRPX and HMCN1 regulated the invasiveness of OC via the Ras homology family member A (RhoA) signaling pathway in fibroblasts. Therefore, the findings of the present study suggest that targeting the CAF genes, SRPX and HMCN1, can inhibit OC migration and invasion. These data highlight the importance of CAFOC crosstalk signaling in cancer invasion and demonstrate the potential for improved efficacy of OC treatment by targeting CAFSRPX/HMCN1.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31638245     DOI: 10.3892/or.2019.7379

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  9 in total

1.  Robust prognostic model based on immune infiltration-related genes and clinical information in ovarian cancer.

Authors:  Xi Zhang; Weikaixin Kong; Miaomiao Gao; Weiran Huang; Chao Peng; Zhuo Huang; Zhengwei Xie; Hongyan Guo
Journal:  J Cell Mol Med       Date:  2022-06-23       Impact factor: 5.295

Review 2.  A Comparison of Chemotherapy Used with and without Apatinib for Patients with Ovarian Carcinoma Who Progressed after Standard Regimens: A Systematic Review and Meta-Analysis.

Authors:  Chao Hou; Zhuang-Zhuang Jiang; Bo Pan; Xiao-Chun Zhang; Yan-Qing Liu
Journal:  Evid Based Complement Alternat Med       Date:  2021-11-03       Impact factor: 2.629

3.  GLIS1 in Cancer-Associated Fibroblasts Regulates the Migration and Invasion of Ovarian Cancer Cells.

Authors:  Mi Joung Kim; Daun Jung; Joo Youn Park; Seung Min Lee; Hee Jung An
Journal:  Int J Mol Sci       Date:  2022-02-17       Impact factor: 5.923

4.  Integrated Machine Learning and Bioinformatic Analyses Constructed a Novel Stemness-Related Classifier to Predict Prognosis and Immunotherapy Responses for Hepatocellular Carcinoma Patients.

Authors:  Dongjie Chen; Jixing Liu; Longjun Zang; Tijun Xiao; Xianlin Zhang; Zheng Li; Hongwei Zhu; Wenzhe Gao; Xiao Yu
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

5.  Identification of Pan-Cancer Biomarkers Based on the Gene Expression Profiles of Cancer Cell Lines.

Authors:  ShiJian Ding; Hao Li; Yu-Hang Zhang; XianChao Zhou; KaiYan Feng; ZhanDong Li; Lei Chen; Tao Huang; Yu-Dong Cai
Journal:  Front Cell Dev Biol       Date:  2021-11-30

6.  Comprehensive Analysis of HMCN1 Somatic Mutation in Clear Cell Renal Cell Carcinoma.

Authors:  Ziqi Gong; Xiaowen Wu; Qian Guo; Haizhen Du; Fenghao Zhang; Yan Kong
Journal:  Genes (Basel)       Date:  2022-07-20       Impact factor: 4.141

7.  Identification and validation of an immune-related gene prognostic signature for clear cell renal carcinoma.

Authors:  Shan Hua; Zhiwen Xie; Yongqing Zhang; Lei Wu; Fei Shi; Xingjie Wang; Shujie Xia; Shengli Dong; Juntao Jiang
Journal:  Front Immunol       Date:  2022-07-22       Impact factor: 8.786

8.  Artemisinin relieves myocardial ischemia-reperfusion injury via modulating miR-29b-3p and hemicentin 1.

Authors:  Junyu Han; Ziguan Zhang; Zhonghe Zhang; Shuyu Yang
Journal:  Front Pharmacol       Date:  2022-08-11       Impact factor: 5.988

9.  Construction and Comprehensive Prognostic Analysis of a lncRNA-miRNA-mRNA Regulatory Network and Tumor Immune Cell Infiltration in Colorectal Cancer.

Authors:  Xiong Guo; Xiaolong Liang; Yujun Wang; Anqi Cheng; Chuan Qin; Han Zhang; Ziwei Wang
Journal:  Front Genet       Date:  2021-07-01       Impact factor: 4.599

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.